Breaking News Instant updates and real-time market news.

AMRN

Amarin

$21.03

-0.26 (-1.22%)

20:10
11/10/18
11/10
20:10
11/10/18
20:10

Amarin to hold an analyst and investor meeting with conference call hookup

Investor and Analyst Meeting to discuss the REDUCE-IT Trial results as presented at the American Heart Association's Scientific Sessions will be held in New York on November 10 at 8:15 pm. Webcast Link

  • 10

    Nov

  • 10

    Nov

  • 10

    Nov

AMRN Amarin
$21.03

-0.26 (-1.22%)

11/08/18
11/08/18
INITIATION

On The Fly: Top analyst initiations
Catch up on today's top analyst initiations with this list compiled by The Fly: 1. Stanley Black & Decker (SWK) initiated with a Hold at Deutsche Bank. 2. Comcast (CMCSA) resumed with an Overweight at Morgan Stanley while Amarin (AMRN) and Immunomedics (IMMU) were assumed with a Buy at the firm. 3. Broadcom (AVGO) resumed with a Buy at Deutsche Bank and reinstated with an Overweight at JPMorgan. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
11/08/18
JEFF
11/08/18
INITIATION
Target $30
JEFF
Buy
Amarin assumed with a Buy at Jefferies
Jefferies analyst Michael Yee assumed coverage of Amarin with a Buy rating and $30 price target. The analyst sees "semi-high expectations" going into the American Heart Association meeting but he believes investors will come away after the event saying the "data looks good." Further, Amarin is a potential takeover candidate going into 2019 "so the path to least resistance is higher," Yee tells investors in a research note. Based on industry fundamentals Amarin represents "one of only a handful of scarce M&A assets for big pharma and existing pharma metabolic-focused salesforce," says Yee.
11/05/18
RHCO
11/05/18
NO CHANGE
Target $30
RHCO
Buy
Amarin price target raised to $30 from $15 at SunTrust
SunTrust analyst John Boris raised his price target on Amarin to $30 and kept his Buy rating, saying its REDUCE-IT data on Vascepa at the upcoming American Heart Association meeting its expected to show "unprecedented benefits in sub-populations & decrease in hospitalizations". The analyst models the program's sales at $2.5B in 2024 amid a "paradigm shift" in therapy with a long post-loss of exclusivity tail comparable to that of Lovaza.
11/02/18
SBSH
11/02/18
DOWNGRADE
Target $28
SBSH
Neutral
Citi now sees limited upside in Amarin, downgrades to Neutral
Citi analyst Joel Beatty downgraded Amarin to Neutral from Buy while raising his price target for the shares to $28 from $25. The analyst still believe that Vascepa is an attractive drug that will exceed $3B in sales. However, he thinks investor expectations have increased substantially over recent weeks, "such that upside is likely to be limited over the coming months, with the possible exception of an acquisition."

TODAY'S FREE FLY STORIES

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
02/20/19
02/20
15:17
02/20/19
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
02/20/19
02/20
15:16
02/20/19
15:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:15
02/20/19
02/20
15:15
02/20/19
15:15
General news
U.S. Treasury Market Summary »

U.S. Treasury Market…

MRAM

Everspin Technologies

$8.63

1.21 (16.31%)

, INTC

Intel

$51.32

-0.07 (-0.14%)

15:11
02/20/19
02/20
15:11
02/20/19
15:11
Periodicals
Intel calls embedded MRAM ready for high-volume manufacturing, EE Times says »

Intel (INTC), in a paper…

MRAM

Everspin Technologies

$8.63

1.21 (16.31%)

INTC

Intel

$51.32

-0.07 (-0.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 21

    Feb

  • 25

    Feb

  • 25

    Feb

  • 14

    Mar

  • 14

    Mar

  • 25

    Mar

  • 26

    Mar

NOG

Northern Oil and Gas

$2.56

0.04 (1.59%)

15:10
02/20/19
02/20
15:10
02/20/19
15:10
Options
Notable call buying in Northern Oil and Gas »

Notable call buying in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 18

    Mar

15:06
02/20/19
02/20
15:06
02/20/19
15:06
General news
Farm Prices data reported »

December Farm Prices down…

15:06
02/20/19
02/20
15:06
02/20/19
15:06
General news
Farm Prices data reported »

December Farm Prices up…

NTES

NetEase

$231.03

1.48 (0.64%)

15:04
02/20/19
02/20
15:04
02/20/19
15:04
Options
NetEase options imply 10.6% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

ITHUF

iAnthus

$0.00

(0.00%)

15:02
02/20/19
02/20
15:02
02/20/19
15:02
Periodicals
Breaking Periodicals news story on iAnthus »

Hedgeye names iAnthus a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EXP

Eagle Materials

$77.88

1.21 (1.58%)

15:00
02/20/19
02/20
15:00
02/20/19
15:00
Options
Notable call buying in Eagle Materials as shares fly to multi-month highs »

Notable call buying in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

MCS

Marcus

$40.94

1.35 (3.41%)

, NCMI

National CineMedia

$7.13

0.11 (1.57%)

14:57
02/20/19
02/20
14:57
02/20/19
14:57
Hot Stocks
Marcus announces affiliate partnership for Movie Tavern with National CineMedia »

National CineMedia (NCMI)…

MCS

Marcus

$40.94

1.35 (3.41%)

NCMI

National CineMedia

$7.13

0.11 (1.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 02

    Apr

  • 02

    Apr

  • 06

    Jun

14:50
02/20/19
02/20
14:50
02/20/19
14:50
General news
Treasury Action: there wasn't any strong reaction to the FOMC minutes »

Treasury Action: there…

SSNLF

Samsung

$0.00

(0.00%)

14:49
02/20/19
02/20
14:49
02/20/19
14:49
Hot Stocks
Samsung introduces new line of Galaxy S10 phones »

Samsung inroduced a new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIPS

Vipshop

$7.28

0.33 (4.75%)

14:49
02/20/19
02/20
14:49
02/20/19
14:49
Options
Vipshop options imply 15.9% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

SSNLF

Samsung

$0.00

(0.00%)

, TMUS

T-Mobile

$72.78

0.27 (0.37%)

14:47
02/20/19
02/20
14:47
02/20/19
14:47
Hot Stocks
Samsung unveils Galaxy Fold »

Samsung Electronics…

SSNLF

Samsung

$0.00

(0.00%)

TMUS

T-Mobile

$72.78

0.27 (0.37%)

T

AT&T

$30.87

0.24 (0.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 11

    Mar

  • 11

    Mar

  • 20

    Mar

VRTU

Virtusa

$50.50

-0.61 (-1.19%)

14:46
02/20/19
02/20
14:46
02/20/19
14:46
Conference/Events
Virtusa management to meet with JPMorgan »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 25

    Feb

  • 28

    Feb

  • 01

    Mar

  • 04

    Mar

  • 05

    Mar

  • 19

    Mar

ADI

Analog Devices

$106.55

2.34 (2.25%)

14:46
02/20/19
02/20
14:46
02/20/19
14:46
Recommendations
Analog Devices analyst commentary  »

Analog Devices price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 25

    Feb

  • 13

    Mar

  • 09

    Apr

  • 28

    May

SSNLF

Samsung

$0.00

(0.00%)

14:44
02/20/19
02/20
14:44
02/20/19
14:44
Hot Stocks
Samsung unveils Galaxy Watch Active, Galaxy Fit, and Galaxy Buds »

Samsung Electronics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NAK

Northern Dynasty

$0.89

0.0029 (0.33%)

14:44
02/20/19
02/20
14:44
02/20/19
14:44
Hot Stocks
Northern Dynasty says Pebble Project Draft Environmental Impact Statement posted »

Northern Dynasty Minerals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSCO

Tractor Supply

$97.56

0.53 (0.55%)

14:42
02/20/19
02/20
14:42
02/20/19
14:42
Conference/Events
Tractor Supply management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 26

    Feb

  • 06

    Mar

PWR

Quanta Services

$36.49

0.815 (2.28%)

14:40
02/20/19
02/20
14:40
02/20/19
14:40
Options
Repeat put buyers in Quanta Services ahead of earnings »

Repeat put buyers in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

EADSY

Airbus

$0.00

(0.00%)

14:38
02/20/19
02/20
14:38
02/20/19
14:38
Conference/Events
Airbus management to meet with JPMorgan »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

NTR

Nutrien

$54.57

1.22 (2.29%)

14:35
02/20/19
02/20
14:35
02/20/19
14:35
Options
Nutrien put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

  • 24

    Feb

  • 27

    Feb

  • 27

    Feb

14:35
02/20/19
02/20
14:35
02/20/19
14:35
General news
On the balance sheet: »

On the balance sheet: the…

SSNLF

Samsung

$0.00

(0.00%)

, VZ

Verizon

$55.67

0.24 (0.43%)

14:34
02/20/19
02/20
14:34
02/20/19
14:34
Periodicals
Samsung unveils Galaxy S10 5G, Verge reports »

Samsung (SSNLF) intends…

SSNLF

Samsung

$0.00

(0.00%)

VZ

Verizon

$55.67

0.24 (0.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 03

    Mar

  • 03

    Mar

  • 11

    Mar

  • 11

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.